Department of Pharmacy, 38032Taipei Medical University, Wan Fang Hospital, Taipei Medical University, Taipei.
Department of Clinical Pharmacy, School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei.
J Int Med Res. 2021 Nov;49(11):3000605211055415. doi: 10.1177/03000605211055415.
To evaluate the effectiveness of the collaboration between oncology pharmacists and anaesthesiologists for improving pain control management in cancer patients.
This retrospective case-control pilot study enrolled inpatients with active cancer and a pain score of >3 at least once per day for 3 consecutive days. The study group was selected from June 2018 to January 2019. Patients with the same inclusion criteria were selected between November 2017 and May 2018 to serve as the comparison group. The primary outcome was the percentage of patients that experienced pain relief within 7 days from initial pain attack.
A total of 71 and 77 patients were enrolled in the study and comparison groups. More patients in the study group experienced pain relief within 7 days from the index date (78.9% [56 of 71 patients] versus 72.7% [56 of 77 patients], respectively). The service increased the rate of intervention from attending physicians within 4 days from index date and quality of opioid management.
The collaboration between oncology pharmacists and anaesthesiologists for cancer pain management may be associated with an increase in the rate of pain relief in cancer patients with poor pain control.
评估肿瘤药师与麻醉师合作改善癌症患者疼痛管理控制的效果。
本回顾性病例对照研究纳入至少连续 3 天每天至少出现 1 次疼痛评分>3 的活动性癌症住院患者。研究组患者选自 2018 年 6 月至 2019 年 1 月,同期选取相同纳入标准的患者作为对照组。主要结局为首次疼痛发作后 7 天内疼痛缓解的患者比例。
共纳入 71 例和 77 例研究组和对照组患者。研究组中更多患者在索引日期后 7 天内疼痛缓解(78.9%[56/71 例]比 72.7%[56/77 例])。该服务增加了从索引日期起 4 天内主治医生干预的比例,并改善了阿片类药物管理的质量。
肿瘤药师与麻醉师合作进行癌症疼痛管理可能与改善疼痛控制不佳的癌症患者的疼痛缓解率有关。